veoexrmpzt
Dołączył: 21 Lut 2011
Posty: 371
Przeczytał: 0 tematów
Ostrzeżeń: 0/5
Skąd: England
|
 Wysłany: Nie 12:19, 20 Mar 2011 Temat postu: mulberry bags pyz ysn joqz hsc |
 |
|
,[link widoczny dla zalogowanych]
Pharmaceutical product development and selection of new
In fact these three are very particular about the acquisition: Shandong Dezhou-based pharmaceutical drugs to tumors in the preparation of raw materials and cisplatin in a leading position on: Shandong Heze in the pharmaceutical Naoxintong excellent complementary medicine varieties as the same species in the brain through the heart of a huge sales network in the home can easily import the other pharmaceutical companies in the acquisition of Jinan, Jinan, later renamed the step Pharmaceutical Co., Ltd., which merged into the main production line is to fill the step in traditional Chinese medicine injection production line, less than, first of all not to mention investment in a Chinese medicine injection production line costs are, one to form a stable technology and skilled personnel costs to the step of saving a lot of money, step in This developed into his Approval documents for most businesses to buy favorite ways to add new products, however, the species currently on the market, has the potential to have a good variety on the market has been unofficially crowned much earlier, when we filled with envy to see other companies and on a good variety of exclusive, we ignored the business as early as two to three years or earlier in the medical world 20o5 74 2 years time has been invested in the funds or technology to do so developed. We can refer to the field of liver disease is currently flourishing in Lianyungang Chia Tai Pharmaceutical sunny situation. ★ 1987 launched a strong licorice acid treatment of hepatitis Ning. ★ 1990 launch of immunomodulatory treatment for hepatitis drug PUPS. ★ 1994 Grey launched the treatment of hepatitis drug glycyrrhizin glycyrrhizin (glycyrrhizic acid diammonium). -A -A ★ 2003 年 4 launched a new drug treatment of chronic hepatitis fine Sunningdale. -A From 1987 to 2004, 18 years to ask, Chia Tai Ching an average of less than 3 years to launch a liver disease drug. China Zhengda fine now occupy 12% of liver disease drug market share, in 2003, leading products Chia Tai Ching's In the field of liver disease has been bigger and stronger. Chia Tai Ching's success, the reference number of domestic SMEs lies, business ideas on the choice of R & D should have continuity, to play its own characteristics, strengths. R & D institutions is the development of long-term the only way new drugs strategy, corporate quality and cheap if you want to get new products to be involved in early drug development process, while the mechanism is present, the majority of research and development of state-owned research institutes speed and quality of important issues, therefore, for most SMEs, selected as partners in the private R & D institutions more able to achieve win-win situation. Therefore,[link widoczny dla zalogowanych], enterprises in research and development strategy, should be concerned about the short-term product development in the present, to meet the current needs of the production or survival,[link widoczny dla zalogowanych], while long-term development projects to proceed as soon as possible, we believe that short-term: neutral: long-term ratio between the most appropriate should be 10:3 : 1, and the development time should be synchronized, in the product approval, to have formed the team, to avoid the other. At the same time, enterprises need according to their own situation to their own position clear: the market leader - Market challenger - followers of SMEs are often difficult to achieve market leader in the market, but formed its own characteristics in the individual areas, a special a leader or small classes, such as the Qinghai Pharmaceutical advantage with Ma control drugs into one of the leading such drugs,[link widoczny dla zalogowanych], the injection of morphine has been leading the market share in certain specialist areas, such as the current pediatric professional the field of drugs, not the formation of specialized and powerful enterprises, some enterprises in these areas can form a series, features, as the market challenger: the strength of the smaller companies to follow the strategy of taking the conventional choice, but also To some things,[link widoczny dla zalogowanych], choose the segment of the market, in the local market superiority. As previously indicated, the current status of the short-term oriented R & D are generic and the change in a positive formulation of the drug injection and oral administration of Chinese medicine formulations account for changes in the mainstream market. Although such an approach is a short-term behavior, but for from the current situation of SMEs is the only way, because there is no need to short-term species amplification products, but this choice should be a purpose, should be combined with the formation of long-term development of enterprises sequence development. Pro Yuan Xian fish, as retreat webs. Park
Post został pochwalony 0 razy
|
|
